Are penny stocks a must-have or a must-avoid? Well, that depends on who you ask. There’s no middle ground when it comes to these tickers trading for less than $5 per share; those on the Street are either fans or harsh critics. Both sides make sense. The naysayers argue that the bargain price is just too good to be true, with it potentially indicating there are problems hiding beneath the surface like weak fundamentals or overwhelming headwinds. However, the investors that are pro-penny stocks ju
Century Therapeutics (NASDAQ:IPSC – Get Free Report) and Athira Pharma (NASDAQ:ATHA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, earnings, analyst recommendations, profitability and risk. Valuation and Earnings This table compares Century […]
Psychosis in Parkinson's and Alzheimer's Disease Market Size in the 7MM is anticipated to increase by 2034, estimates DelveInsight medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
Athira Pharma's ATH-1105 Shows Promise for ALS in Neuroscience Study miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Dr. Leen Kawas, Managing General Partner at Propel Bio Partners, highlights the myriad of ways in which a diverse management team can positively impact an entire workforce. In today’s increasingly global business landscape, workers with different nationalities and cultural profiles often come together to help achieve a company’s mission. Individuals…